We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

115 hedge funds and large institutions have $974M invested in MyoKardia, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

444% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 9

371% more capital invested

Capital invested by funds: $207M → $974M (+$767M)

81% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 21

53% more funds holding

Funds holding: 75 → 115 (+40)

Holders
115
Holders Change
+40
Holders Change %
+53.33%
% of All Funds
2.87%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
49
Increased
38
Reduced
21
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$34.6M
2
EC
EcoR1 Capital
California
+$22M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.6M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$18.8M
5
BlackRock
BlackRock
New York
+$17.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.1M
2
JP Morgan Chase
JP Morgan Chase
New York
-$10M
3
Millennium Management
Millennium Management
New York
-$7.12M
4
MWNA
Marshall Wace North America
New York
-$4.46M
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$2.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$8.74M +$4.94M +154,797 +314%
HIM
27
Hillhouse Investment Management
Cayman Islands
$8.24M +$6.13M +192,213 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$7.96M +$1.24M +38,958 +27%
Invesco
29
Invesco
Georgia
$7.7M +$5.73M +179,645 New
JP Morgan Chase
30
JP Morgan Chase
New York
$6.94M -$10M -313,500 -66%
TCIM
31
TIAA CREF Investment Management
New York
$6.5M +$1.58M +49,448 +48%
RPAM
32
Rhenman & Partners Asset Management
Sweden
$6.46M +$4.81M +150,872 New
HP
33
Harbourvest Partners
Massachusetts
$5.16M +$2.43M +76,242 +173%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$4.66M +$1.45M +45,446 +72%
CS
35
Candriam SCA
Luxembourg
$4.54M +$3.38M +106,000 New
EI
36
EAM Investors
California
$4.22M +$3.14M +98,390 New
Two Sigma Investments
37
Two Sigma Investments
New York
$3.85M +$2.87M +89,895 New
USAA
38
United Services Automobile Association
Texas
$3.64M +$66.8K +2,095 +3%
UBS Group
39
UBS Group
Switzerland
$3.52M +$2.62M +82,121 New
PAM
40
Panagora Asset Management
Massachusetts
$3.49M +$1.87M +58,596 +256%
OAM
41
Oxford Asset Management
United Kingdom
$3.47M -$1.67M -52,458 -39%
Charles Schwab
42
Charles Schwab
California
$3.46M +$739K +23,172 +40%
EAM
43
Eventide Asset Management
Massachusetts
$3.13M +$2.33M +73,000 New
NFA
44
Nationwide Fund Advisors
Ohio
$2.95M +$1.89M +59,199 +608%
NI
45
Numeric Investors
Massachusetts
$2.87M +$1.52M +47,500 +245%
BIM
46
Bogle Investment Management
Massachusetts
$2.83M +$2.11M +66,001 New
Axa
47
Axa
France
$2.77M +$2.06M +64,555 New
CS
48
Credit Suisse
Switzerland
$2.66M +$1.98M +62,000 New
JRP
49
Jasper Ridge Partners
California
$2.58M +$1.92M +60,196 New
ACM
50
Atika Capital Management
New York
$2.4M +$1.79M +56,000 New
1
2
3 4 5

MYOK Hedge Fund Activity: Q3 2017 in Review

115 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2017, worth a combined $974M — up 371% from $207M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new MYOK positions and 9 closed out — a net gain of 40 holders — while 38 added to existing stakes and 21 trimmed.

The largest buyer was Deerfield Management, adding an estimated $34.6M. The largest seller was Fidelity Investments, cutting an estimated $16.1M.

  • 115 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2017, up from 75 in Q2 2017.
  • Funds reported $974M of MyoKardia, Inc. Common Stock stock for Q3 2017, up 371% quarter-over-quarter.
  • 49 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2017 and 9 closed out, a net change of +40 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q3 2017 was Deerfield Management, an estimated $34.6M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q3 2017 was Fidelity Investments, an estimated $16.1M sold.

Based on aggregated 13F filings for Q3 2017.